bristoldrv Posted March 11, 2019 Report Share Posted March 11, 2019 Bristol's Acquisition Of Celgene Gets Boost On Cancer Treatment News Investor's Business DailyBristol's acquisition of Celgene got a boost Thursday on a patent decision regarding cancer treatment Revlimid. Celgene stock rose a fraction. View the full article Quote Link to comment Share on other sites More sharing options...